HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Dawkins, K. Search for Related Content PubMed Articles by Dawkins, K.

Eur J Cardiothorac Surg 2004;26:S25-S26
© 2004 Elsevier Science NL

Review

View from the cardiologist

Wessex Cardiothoracic Surgery Centre, Southampton University Hospital, Southampton SO16 6YD, UK

Dr Keith Dawkins, a consultant cardiologist at Southampton General Hospital in the UK and President of the British Cardiovascular Intervention Society outlined the explosive growth in cardiological treatments for coronary heart disease, including drugs and percutaneous interventions. He challenged surgeons to accept the inevitable reduction in requirement for surgical revascularisation and to explore alternative areas for development. He indicated that emerging technologies would also impact on valve surgery. He warned that complancency and failure to recognise the need to change was the greatest threat facing the speciality.

Key Words: Percutaneous interventions • Cardiological treatment • Valve surgery